AssetMark Inc’s IDEAYA Biosciences IDYA Stock Holding History

AssetMark Inc’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.42M	Sell	65,021 -611	-0.9%	-$18.7K	﹤0.01%	906
2026 Q1	$2.19M	Sell	65,632 -6,305	-9%	-$212K	﹤0.01%	869
2025 Q4	$2.49M	Sell	71,937 -4,306	-6%	-$137K	0.01%	803
2025 Q3	$2.07M	Buy	76,243 +13,657	+22%	+$330K	﹤0.01%	805
2025 Q2	$1.32M	Buy	62,586 +12,836	+26%	+$246K	﹤0.01%	863
2025 Q1	$815K	Buy	49,750 +4,481	+10%	+$95.5K	﹤0.01%	897
2024 Q4	$1.16M	Buy	45,269 +1,084	+2%	+$30.7K	﹤0.01%	819
2024 Q3	$1.4M	Buy	44,185 +4,481	+11%	+$170K	﹤0.01%	727
2024 Q2	$1.39M	Buy	39,704 +14,013	+55%	+$555K	﹤0.01%	694
2024 Q1	$1.13M	Buy	+25,691	New	+$1.1M	﹤0.01%	704

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AssetMark Inc's IDYA Position: Q2 2026 in Review

AssetMark Inc reduced its IDEAYA Biosciences (IDYA) stake by 0.93% in Q2 2026, selling an estimated $18.7K and leaving 65,021 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #906.

AssetMark Inc first reported a position in IDYA in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.49M in Q4 2025. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

AssetMark Inc held 65,021 shares of IDEAYA Biosciences worth $2.42M as of Q2 2026.
AssetMark Inc sold 611 IDEAYA Biosciences shares in Q2 2026, an estimated $18.7K.
IDEAYA Biosciences made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #906 holding.
AssetMark Inc first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 10 quarters since.
AssetMark Inc's IDEAYA Biosciences position peaked at $2.49M in Q4 2025.
285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.